Bleeding Risk With Concomitant VEGF TKI and Anticoagulation
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Oncologist
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Retrospective Study of Bleeding Risk with Concomitant Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor and Anticoagulation
Oncologist 2021 Nov 01;26(11)e2061-e2069, A Sivakumar, SE Caulfield, C Zhang, S Goyal, MA Bilen, TJ BeardsleeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.